Mo R. Ebrahimkhani

3.7k total citations
54 papers, 2.6k citations indexed

About

Mo R. Ebrahimkhani is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Mo R. Ebrahimkhani has authored 54 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Hepatology and 11 papers in Surgery. Recurrent topics in Mo R. Ebrahimkhani's work include Liver physiology and pathology (13 papers), CRISPR and Genetic Engineering (11 papers) and Pluripotent Stem Cells Research (9 papers). Mo R. Ebrahimkhani is often cited by papers focused on Liver physiology and pathology (13 papers), CRISPR and Genetic Engineering (11 papers) and Pluripotent Stem Cells Research (9 papers). Mo R. Ebrahimkhani collaborates with scholars based in United States, Iran and United Kingdom. Mo R. Ebrahimkhani's co-authors include Samira Kiani, Ian Nicholas Crispe, Linda G. Griffith, Ahmad Reza Dehpour, Ron Weiss, Isaac Mohar, Jeremy J. Velazquez, Alejandro Chavez, Jacob Beal and Richard Hall and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Mo R. Ebrahimkhani

53 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo R. Ebrahimkhani United States 30 1.5k 438 427 309 284 54 2.6k
Gareth J. Sullivan Norway 27 1.9k 1.2× 387 0.9× 303 0.7× 428 1.4× 209 0.7× 68 2.9k
Yanxia Liu United States 24 2.9k 1.9× 371 0.8× 418 1.0× 520 1.7× 135 0.5× 35 3.7k
Yujiro Tanaka Japan 30 2.0k 1.3× 226 0.5× 345 0.8× 524 1.7× 191 0.7× 72 3.6k
Cong Ma China 28 1.7k 1.1× 189 0.4× 175 0.4× 233 0.8× 279 1.0× 142 3.2k
Sven C.D. van IJzendoorn Netherlands 34 1.5k 1.0× 86 0.2× 329 0.8× 539 1.7× 301 1.1× 76 2.9k
Chiara Collesi Italy 22 1.8k 1.2× 65 0.1× 297 0.7× 459 1.5× 167 0.6× 34 3.0k
Yi Arial Zeng China 27 1.7k 1.2× 318 0.7× 67 0.2× 410 1.3× 210 0.7× 82 3.3k
John Lincecum United States 16 2.5k 1.6× 65 0.1× 240 0.6× 291 0.9× 252 0.9× 16 4.2k
Joep Beumer Netherlands 21 1.2k 0.8× 416 0.9× 65 0.2× 434 1.4× 151 0.5× 30 2.7k
Cristina Fillat Spain 32 1.7k 1.1× 161 0.4× 87 0.2× 303 1.0× 205 0.7× 114 3.1k

Countries citing papers authored by Mo R. Ebrahimkhani

Since Specialization
Citations

This map shows the geographic impact of Mo R. Ebrahimkhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo R. Ebrahimkhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo R. Ebrahimkhani more than expected).

Fields of papers citing papers by Mo R. Ebrahimkhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo R. Ebrahimkhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo R. Ebrahimkhani. The network helps show where Mo R. Ebrahimkhani may publish in the future.

Co-authorship network of co-authors of Mo R. Ebrahimkhani

This figure shows the co-authorship network connecting the top 25 collaborators of Mo R. Ebrahimkhani. A scholar is included among the top collaborators of Mo R. Ebrahimkhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo R. Ebrahimkhani. Mo R. Ebrahimkhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velazquez, Jeremy J., et al.. (2023). Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols. Stem Cell Reports. 18(8). 1721–1742. 3 indexed citations
2.
Shafritz, David A., Mo R. Ebrahimkhani, & Michael Oertel. (2023). Therapeutic Cell Repopulation of the Liver: From Fetal Rat Cells to Synthetic Human Tissues. Cells. 12(4). 529–529. 3 indexed citations
3.
Li, Dongshunyi, et al.. (2022). TraSig: inferring cell-cell interactions from pseudotime ordering of scRNA-Seq data. Genome biology. 23(1). 73–73. 12 indexed citations
4.
Moghadam, Farzaneh, Jeremy J. Velazquez, Nan Cher Yeo, et al.. (2020). Synthetic immunomodulation with a CRISPR super-repressor in vivo. Nature Cell Biology. 22(9). 1143–1154. 28 indexed citations
5.
Ebrahimkhani, Mo R., et al.. (2020). CRISPR-Based Synthetic Transcription Factors In Vivo: The Future of Therapeutic Cellular Programming. Cell Systems. 10(1). 1–14. 47 indexed citations
6.
Gough, Albert, Alejandro Soto–Gutiérrez, Lawrence A. Vernetti, et al.. (2020). Human biomimetic liver microphysiology systems in drug development and precision medicine. Nature Reviews Gastroenterology & Hepatology. 18(4). 252–268. 85 indexed citations
7.
Velazquez, Jeremy J., Farzaneh Moghadam, Yuqi Tan, et al.. (2020). Gene Regulatory Network Analysis and Engineering Directs Development and Vascularization of Multilineage Human Liver Organoids. Cell Systems. 12(1). 41–55.e11. 64 indexed citations
8.
Chavez, Alejandro, Marcelle Tuttle, Raj Chari, et al.. (2015). Cas9 gRNA engineering for genome editing, activation and repression. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations
9.
Kiani, Samira, Alejandro Chavez, Marcelle Tuttle, et al.. (2015). Cas9 gRNA engineering for genome editing, activation and repression. Nature Methods. 12(11). 1051–1054. 249 indexed citations
10.
Mohar, Isaac, Katherine J. Brempelis, Sara A. Murray, Mo R. Ebrahimkhani, & Ian Nicholas Crispe. (2015). Isolation of Non-parenchymal Cells from the Mouse Liver. Methods in molecular biology. 1325. 3–17. 50 indexed citations
11.
Ebrahimkhani, Mo R., et al.. (2014). Bioreactor technologies to support liver function in vitro. Advanced Drug Delivery Reviews. 69-70. 132–157. 109 indexed citations
12.
Ebrahimkhani, Mo R., Carissa L. Young, Douglas A. Lauffenburger, Linda G. Griffith, & Jeffrey T. Borenstein. (2014). Approaches to in vitro tissue regeneration with application for human disease modeling and drug development. Drug Discovery Today. 19(6). 754–762. 35 indexed citations
13.
Ebrahimkhani, Mo R., Isaac Mohar, & Ian Nicholas Crispe. (2011). Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology. 54(4). 1379–1387. 83 indexed citations
14.
Ebrahimkhani, Mo R., Ahmed M. Elsharkawy, & Derek A. Mann. (2008). Wound healing and local neuroendocrine regulation in the injured liver. Expert Reviews in Molecular Medicine. 10. e11–e11. 11 indexed citations
15.
Riazi, Kiarash, Hooman Honar, Houman Homayoun, et al.. (2005). The synergistic anticonvulsant effect of agmatine and morphine: Possible role of alpha 2-adrenoceptors. Epilepsy Research. 65(1-2). 33–40. 28 indexed citations
16.
Salmasi, Amirali, Seyedmehdi Payabvash, Shadpour Demehri, et al.. (2005). Effect of morphine on ischemia-reperfusion injury: Experimental study in testicular torsion rat model. Urology. 66(6). 1338–1342. 50 indexed citations
17.
Ebrahimkhani, Mo R., Hamed Sadeghipour, Samira Kiani, et al.. (2005). Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. Life Sciences. 76(21). 2497–2512. 18 indexed citations
18.
Honar, Hooman, Kiarash Riazi, Houman Homayoun, et al.. (2004). Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience. 129(3). 733–742. 40 indexed citations
19.
Honar, Hooman, Kiarash Riazi, Hamed Shafaroodi, et al.. (2004). Obstructive cholestasis alters intestinal transit in mice: role of opioid system. Life Sciences. 76(4). 397–406. 15 indexed citations
20.
Sadeghipour, Hamed, Hooman Honar, Kiarash Riazi, et al.. (2004). Time-dependent reduction of acetylcholine-induced relaxation in corpus cavernosum of cholestatic rats: role of nitric oxide and cyclooxygenase pathway. European Journal of Pharmacology. 496(1-3). 181–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gareth J. Sullivan Breakdown of academic impact, for papers by Yanxia Liu Breakdown of academic impact, for papers by Yujiro Tanaka Breakdown of academic impact, for papers by Cong Ma Breakdown of academic impact, for papers by Sven C.D. van IJzendoorn Breakdown of academic impact, for papers by Chiara Collesi Breakdown of academic impact, for papers by Yi Arial Zeng Breakdown of academic impact, for papers by John Lincecum Breakdown of academic impact, for papers by Joep Beumer Breakdown of academic impact, for papers by Cristina Fillat
Rankless by CCL
2026